GLP-1 receptor agonists associated with better cardiovascular outcomes in obese or diabetic patients with elevated Lp(a) levels: A Multicenter retrospective study
Wegovy and Zepbound could both be covered for the treatment of weight loss (an FDA-approved use) but would not be approved for use in treating Type 2 diabetes
These drugs also may help some people lose weight
Basic Clin Pharmacol Toxicol 119(6):555561 Shi J, Wang X, Nguyen JH, Bleske BE, Liang Y, Liu L, Zhu HJ (2016b) Dabigatran etexilate activation is affected by the CES1 genetic polymorphism G143E (rs71647871) and gender
For whom: Recommended especially for people who are lean Recreational trainers and professional sports Composition * -% of the nutrient reference value Water, L-carnitine, acidity regulator (citric acid), flavor, sweetener (sucralose), preservatives (sodium benzoate, potassium sorbate), color (Allura Red AC)